Skip to main content
GALECTIN THERAPEUTICS INC logo

GALECTIN THERAPEUTICS INC — Investor Relations & Filings

Ticker · GALT ISIN · US3632252025 LEI · 5299004HFYSAZM2ALW85 US Manufacturing
Open in API
Filings indexed 1,091 across all filing types
Latest filing 2012-03-30 Earnings Release
Country US United States of America
Listing US GALT

About GALECTIN THERAPEUTICS INC

https://galectintherapeutics.com/

Galectin Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for fibrotic diseases, chronic liver disease, and cancer. The company's therapeutic approach centers on inhibiting the galectin-3 protein, which is implicated in various inflammatory, fibrotic, and malignant conditions. Its lead drug candidate, belapectin (GR-MD-02), is a proprietary carbohydrate-based drug designed to bind to and inhibit galectin-3. The primary development program for belapectin is focused on treating non-alcoholic steatohepatitis (MASH) with cirrhosis, a serious liver disease with no currently approved therapies.

Recent filings

Filing Released Lang Actions
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated March 30, 2012, by Galectin Therapeutics Inc. It reports the issuance of a press release containing financial information for the year ended December 31, 2011, and the quarter ended December 31, 2011. The document explicitly states that the press release is being furnished and not filed, and it contains no actual financial statements or detailed financial data itself. The length of the document is 2293 characters, which is relatively short and consistent with an announcement rather than a full financial report. According to the 'Menu vs Meal' rule, this is an announcement of financial results, not the results themselves. Therefore, the appropriate classification is Earnings Release (ER), as it is the initial announcement of quarterly/periodical financial results (key highlights only).
2012-03-30 English
FORM 10-K
Annual Report FY 2011
2012-03-30 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The content specifically discusses a one-for-six reverse stock split of the company's common stock and the effect on existing registration statements on Form S-8. This is an announcement of a capital structure change rather than a full financial report or earnings release. The document length is 3650 characters, which is relatively short and consistent with an announcement rather than a detailed report. Therefore, the filing type corresponds to a Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as stock splits.
2012-03-26 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes details about a reverse stock split, an underwriting agreement for a public offering of units (common stock and warrants), listing changes including moving to NASDAQ Capital Market, and related exhibits such as the underwriting agreement, warrant agreement, and a press release. There are no financial statements or comprehensive financial data typical of annual or quarterly reports. The primary focus is on capital raising and changes in capital structure, including stock split and listing changes. Therefore, this document fits best under the category of Capital/Financing Update (CAP).
2012-03-23 English
424(B)(2)
Capital/Financing Update Classification · 100% confidence The document is a prospectus supplement and accompanying prospectus filed pursuant to Rule 424(b)(2) under the Securities Act of 1933. It details an offering of units consisting of common stock and warrants, including pricing, underwriting, risk factors, use of proceeds, and other offering-related information. This type of document is a capital raising disclosure related to financing activities, specifically describing the terms and conditions of a securities offering. It is not a financial report, earnings release, or management discussion, nor is it a regulatory filing unrelated to financing. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length and content confirm it is the actual offering document, not just an announcement or a brief summary.
2012-03-23 English
AUTO-GENERATED PAPER DOCUMENT
Regulatory Filings
2012-03-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.